Change in contrast enhancement of HCC on 1-month follow-up CT after local radiotherapy: An early predictor of final treatment response

European Journal of Radiology

Volumn 72, Issue 3, 2009, Pages 440-446

  Kim, Eun Young ^a   Choi, Dongil ^a   Lim, Do Hoon ^b   Lee, Won Jae ^a   Yoo, Byung Chul ^b   Paik, Seung Woon ^b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Carcinoma; Contrast media; Hepatocellular; Radiotherapy; Tomography; Treatment outcome; X ray computed

Indexed keywords

COMPLETE RESPONSE; CONTRAST ENHANCEMENT; CT SCAN; FOLLOW-UP CT SCAN; HEPATOCELLULAR; PARTIAL RESPONSE; SUBJECTIVE ANALYSIS; TREATMENT OUTCOME; TREATMENT OUTCOMES; TREATMENT RESPONSE; TUMOR SIZE; X-RAY COMPUTED;

COMPUTERIZED TOMOGRAPHY; RADIOTHERAPY; TUMORS;

CONTRAST MEDIA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; IOHEXOL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 70449709293     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.07.036     Document Type: Article

References (22)

1. El-Serag H.B. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35 (2002) S72-S78
2. Hawkins M.A., and Dawson L.A. Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 106 (2006) 1653-1663
3. Dawson L.A., and Ten Haken R.K. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15 (2005) 279-283
4. Yamasaki S.A., Marn C.S., Francis I.R., Robertson J.M., and Lawrence T.S. High-dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis. AJR Am J Roentgenol 165 (1995) 79-84
5. Seong J., Park H.C., Han K.H., and Chon C.Y. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55 (2003) 329-336
6. Matsuura M., Nakajima N., Arai K., and Ito K. The usefulness of radiation therapy for hepatocellular carcinoma. Hepatogastroenterology 45 (1998) 791-796
7. Abou-Alfa G.K., Schwartz L., Ricci S., Amadori D., Santoro A., Figer A., et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 24 (2006) 4293-4300
8. Park W., Lim D.H., Paik S.W., Koh K.C., Choi M.S., Park C.K., et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 61 (2005) 1143-1150
9. Ben-Josef E., and Lawrence T.S. Radiotherapy for unresectable hepatic malignancies. Semin Radiat Oncol 15 (2005) 273-278
10. Hargreaves G.M., Adam R., and Bismuth H. Results after nonsurgical local treatment of primary liver malignancies. Langenbecks Arch Surg 385 (2000) 185-193
11. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001) 421-430
12. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
13. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
14. Schwartz M., Roayaie S., and Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 4 (2007) 424-432
15. Llovet J.M. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40 (2005) 225-235
16. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med. 332 (1995) 1256-1261
17. Ingold J.A., Reed G.B., Kaplan H.S., and Bagshaw M.A. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med 93 (1965) 200-208
18. Wharton J.T., Delclos L., Gallager S., and Smith J.P. Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 117 (1973) 73-80
19. Jang K.M., Choi D., Lim H.K., Lim J.H., Lee J.Y., Lee W.J., et al. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of the previous serial CT images. Korean J Radiol 6 (2005) 153-160
20. Bartolozzi C., Cioni D., and Donati F. Imaging evaluation of tumor response. In: Lencioni R. (Ed). Diagnostic and interventional radiology. (1999), Springer-Verlag, Berlin 467-487
21. Kim H.C., Lee J.M., Choi S.H., Han H., Kim S.S., Lee S.H., et al. Cystic changes in intraabdominal extrahepatic metastases from gastrointestinal stromal tumors treated with imatinib. Korean J Radiol 5 (2004) 157-163
22. Choi H., Charnsangavej C., Faria S.C., Macapinlac H.A., Burgess M.A., Patel S.R., et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25 (2007) 1753-1759